Crystal engineering of the composition of pharmaceutical phases.
about
Non-Covalent Derivatives: Cocrystals and EutecticsTowards an understanding of the propensity for crystalline hydrate formation by molecular compounds.Pharmaceutical Cocrystals and Their Physicochemical Properties.The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics.Pharmaceutical cocrystals: along the path to improved medicines.Binary and ternary cocrystals of sulfa drug acetazolamide with pyridine carboxamides and cyclic amidesModularity and three-dimensional isostructurality of novel synthons in sulfonamide-lactam cocrystals.Redetermined structure of 4,4'-bi-pyridine-1,4-phenyl-enedi-acetic acid (1/1) co-crystal.Eutectics as improved pharmaceutical materials: design, properties and characterization.Multinuclear solid state NMR investigation of two polymorphic forms of ciprofloxacin-saccharinate.Formation of isostructural solid solutions in 2,6-disubstituted N-phenylformamides and N-phenylthioamides.Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
P2860
Q26796674-09144776-6841-4D7C-A000-65B35FA8BF85Q36191359-C85371F6-8756-42E1-A964-852920C96356Q37510600-6709A2B8-9AED-4D55-9FD1-B3E1DB5DB564Q38162929-A3DE26AE-56A6-4A50-BEC2-8993DE33B02FQ38236638-6CE17041-2D1C-42A0-935C-5B3724894667Q38632654-69343957-B85A-4A6F-B188-F76452410C93Q38728161-3E715FE1-F000-4F55-B83F-FAE7F656892EQ41433668-5F330C50-84D8-450F-AA50-8E0FB8E0E8C6Q41806977-620CEEC2-CFD2-4118-A0D5-318F187BF2CDQ44122680-35E37CF3-2E1A-4EC4-93F1-F69EEB195E18Q44607428-D4FB81FA-D210-4124-A0FE-D9C56B503994Q46685426-A9CE1D48-B7AE-4428-AECC-D3B7052D523DQ59234241-60905782-CE9F-4AB0-98B1-3CE78A3D338B
P2860
Crystal engineering of the composition of pharmaceutical phases.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Crystal engineering of the composition of pharmaceutical phases.
@en
Crystal engineering of the composition of pharmaceutical phases.
@nl
type
label
Crystal engineering of the composition of pharmaceutical phases.
@en
Crystal engineering of the composition of pharmaceutical phases.
@nl
prefLabel
Crystal engineering of the composition of pharmaceutical phases.
@en
Crystal engineering of the composition of pharmaceutical phases.
@nl
P2093
P356
P1476
Crystal engineering of the composition of pharmaceutical phases
@en
P2093
L A Morales
M W Bradner
N Rodríguez-Hornedo
R D Bailey Walsh
a B Moulton
a S Fleischman
P304
P356
10.1039/B208574G
P407
P577
2003-01-01T00:00:00Z